Skip to main content

Advertisement

SpringerLink
Log in

Depression and quality of life issues in patients with amyotrophic lateral sclerosis

  • Published:
Current Treatment Options in Neurology Aims and scope Submit manuscript

Opinion statement

Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron disease that usually results in death secondary to respiratory failure. The psychological reaction to the diagnosis of ALS in patient and caregiver has received increasing attention. Reports are highly variable as to the severity of depressive symptoms in patients with ALS. When they exist, depressive symptoms can be managed with pharmacologic interventions. Recognizing cognitive impairment is essential in the management of patients with ALS. Quality of life assessments have been used to further evaluate the reaction to the disease. Maintaining a meaningful quality of life centers on psychological, supportive, and spiritual factors, as opposed to physical status. In addition to the patient’s reaction, there are a variety of responses experienced by caregivers. Clinicians should provide appropriate support to the caregivers of the patients during the course of the illness and after death.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Isselbacher KJ, Braunwald E, Wilson JD, et al.: Harrison’s Principles of Internal Medicine, edn 13. New York: McGraw-Hill Inc.; 1994.

    Google Scholar 

  2. Donaghy M: Brain’s Diseases of the Nervous System, edn 11. New York: Oxford University Press; 2001.

    Google Scholar 

  3. Walling AD: Amyotrophic lateral sclerosis: Lou Gehrig’s disease. Am Fam Physician 1999, 59:1489–1496.

    PubMed  CAS  Google Scholar 

  4. Belsh JM, Schiffman PL: Amyotrophic Lateral Sclerosis: Diagnosis and Management for the Clinician. Armonk, NY: Futura Publishing Company; 1996:41–43.

    Google Scholar 

  5. Rabkin JG, Wagner GJ, Bene MD: Resilience and distress among amyotrophic lateral sclerosis patients and caregivers. Psychosom Med 2000, 62:271–279.

    PubMed  CAS  Google Scholar 

  6. Kilani M, Micallef J, Soubrouillard C, et al.: A longitudinal study of the evolution of cognitive function and affective state in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2004, 5:46–54.

    Article  PubMed  CAS  Google Scholar 

  7. Bungener C, Piquard A, Pradat P, et al.: Psychopathology in amyotrophic lateral sclerosis: a preliminary study with 27 ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord 2005, 6:221–225.

    Article  PubMed  Google Scholar 

  8. Moore MJ, Moore PB, Shaw P: Mood disturbances in motor neuron disease. J Neurol Sci 1998, 160(Suppl 1):S53-S56.

    Article  PubMed  Google Scholar 

  9. Hogg KE, Goldstein L, Leigh P: The psychological impact of motor neuron disease. Psychol Med 1994, 24:625–632.

    Article  PubMed  CAS  Google Scholar 

  10. Tedman BM, Young CA, Williams IR: Assessment of depression in patients with motor neuron disease and other neurologically disabling illnesses. J Neurol Sci 1997, S75–S79.

  11. Rabkin JG, Albert SM, Del Bene ML, et al.: Prevalence of depressive disorders and change over time in late stage ALS. Neurology 2005, 65:62–67. A well-written article and a good reference.

    Article  PubMed  CAS  Google Scholar 

  12. Kubler A, Winter S, Ludolph AC, et al.: Severity of depressive symptoms and quality of life in patients with amyotrophic lateral sclerosis. Neurorehabil Neural Repair 2005, 19:182–193. A complete overview on an important topic for clinicians.

    Article  PubMed  Google Scholar 

  13. Norquist JM, Jenkinson C, Fitzpatrick R, et al.: Factors which predict physical and mental health status in patients with amyotrophic lateral sclerosis over time. Amyotroph Lateral Scler Other Motor Neuron Disord 2003, 4:112–117.

    Article  PubMed  Google Scholar 

  14. Hillemacher T, Grassel E, Tigges S, et al.: Depression and bulbar involvement in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2004, 5:245–249.

    Article  PubMed  Google Scholar 

  15. Simmons Z: Management strategies for patients with amyotrophic lateral sclerosis from diagnosis through death. Neurologist 2005, 11:257–270. This is a thorough overview of this subject.

    Article  PubMed  Google Scholar 

  16. Szcudlik A, Slowik A, Tomik B: The effect of amitriptyline on pathological crying and other pseudobulbar signs. Neurol Neurochir Pol 1995, 29:663–674.

    Google Scholar 

  17. de Oliveira-Souza R, de Figueiredo WM, Andreiuolo PA: Pathological crying and unilateral pontine infarction. Arq Neuropsiquiatr 1995, 53:680–689.

    PubMed  Google Scholar 

  18. Wilson CM, Grace GM, Munoz DG, et al.: Cognitive impairment in sporadic ALS: a pathological continuum underlying a multisystem disorder. Neurology 2001, 57:651–657. A very good overview of this subject.

    PubMed  CAS  Google Scholar 

  19. Portet F, Cadilhac C, Touchon J, et al.: Cognitive impairment in motor neuron disease with bulbar onset. Amyotroph Lateral Scler Other Motor Neuron Disord 2001, 2:23–29.

    Article  PubMed  CAS  Google Scholar 

  20. Lomen-Hoerth C, Anderson T, Miller B: The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 2002, 59:1077–1079.

    Article  PubMed  Google Scholar 

  21. Lomen-Hoerth C, Murphy J, Langmore S, et al.: Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 2003, 60:1094–1097.

    PubMed  CAS  Google Scholar 

  22. McCullagh S, Moore M, Gawel M, et al.: Pathological laughing and crying in amyotrophic lateral sclerosis: an association with prefrontal cognitive dysfunction. J Neurol Sci 1999, 169:43–48.

    Article  PubMed  CAS  Google Scholar 

  23. Cudkowicz ME, Shefner JM, Schoenfeld DA, et al.: A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis. Neurology 2003, 61:456–464. A good study examining topiramate use in ALS.

    PubMed  CAS  Google Scholar 

  24. Amtmann D, Weydt P, Johnson KL, et al.: Survey of cannabis use in patients with amyotrophic lateral sclerosis. Am J Hosp Palliat Care 2004, 21:95–104.

    Article  PubMed  Google Scholar 

  25. Clarke S, Hickey A, O’Boyle C, et al.: Assessing individual quality of life in amyotrophic lateral sclerosis. Qual Life Res 2001, 10:149–158.

    Article  PubMed  CAS  Google Scholar 

  26. Bromberg MB, Forshew DA: Comparison of instruments addressing quality of life in patients with ALS and their caregivers. Neurology 2002, 58:320–322.

    PubMed  Google Scholar 

  27. Nelson ND, Trail M, Van JN, et al.: Quality of life in patients with amyotrophic lateral sclerosis: perceptions, coping resources, and illness characteristics. J Palliat Med 2003, 6:417–424.

    Article  PubMed  CAS  Google Scholar 

  28. Chio A, Gauthier A, Montuschi A, et al.: A cross sectional study on determinants of quality of life in ALS. J Neurol Neurosurg Psychiatry 2004, 75:1597–1601.

    Article  PubMed  CAS  Google Scholar 

  29. Lou JS, Reeves A, Benice T, et al.: Fatigue and depression are associated with poor quality of life in ALS. Neurology 2003, 60:122–123.

    PubMed  Google Scholar 

  30. Plahuta JM, McCulloch BJ, Kasarskis EJ, et al.: Amyotrophic lateral sclerosis and hopelessness: psychosocial factors. Soc Sci Med 2002, 5:2131–2140.

    Article  Google Scholar 

  31. Hecht M, Hillemacher T, Grasel E, et al.: Subjective experience and coping in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2002, 3:225–231.

    PubMed  Google Scholar 

  32. Trail M, Nelson ND, Van JN, et al.: Major stressors facing patients with amyotrophic lateral sclerosis: a survey to identify their concerns and to compare with those of their caregivers. Amyotroph Lateral Scler Other Motor Neuron Disord 2004, 5:40–45.

    Article  PubMed  Google Scholar 

  33. Trail M, Nelson ND, Van JN, et al.: A study comparing patients with amyotrophic lateral sclerosis and their caregivers on measures of quality of life, depression, and their attitudes toward treatment options. J Neurol Sci 2003, 209:79–85.

    Article  PubMed  Google Scholar 

  34. Adelman EE, Albert SM, Rabkin JG, et al.: Disparities in perceptions of distress and burden in ALS patients and family caregivers. Neurology 2004, 62:1766–1770.

    PubMed  CAS  Google Scholar 

  35. Miller RG, Anderson FA Jr, Bradley WG, et al.: The ALS patient care database: goals, design, and early results. ALS CARE Study Group. Neurology 2000, 54:53–57.

    Article  PubMed  CAS  Google Scholar 

  36. Paz-Rodriguez F, Andrade-Palos P, Llanos-Del Pilar AM: Emotional consequences of providing care to amyotrophic lateral sclerosis patients. Rev Neurol 2005, 40:459–464.

    PubMed  CAS  Google Scholar 

  37. Martin J, Turnbull J: Lasting impact in families after death from ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2001, 2:181–187.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Behavioral Health, Denver Health Medical Center, 777 Bannock Street, 80204, Denver, CO, USA

    Shannon F. Stromberg MD

Authors
  1. Shannon F. Stromberg MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David B. Weiss MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stromberg, S.F., Weiss, D.B. Depression and quality of life issues in patients with amyotrophic lateral sclerosis. Curr Treat Options Neurol 8, 410–414 (2006). https://doi.org/10.1007/s11940-006-0030-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11940-006-0030-x

Keywords

Search

Navigation